In doing so and when compared to other blastemal tumors, we identified upregulated expression of the gene encoding the non-canonical WNT ligand WNT5A in both chemotherapy-naïve and chemotherapy-treated blastemal Wilms tumors harboring the SIX1-Q177R mutation. The gene discussed is WNT5A; the disease is Nephroblastoma.